Follow The Filings

BCPC Balchem Corporation

Materials, filed as BALCHEM CORP (COM), Equity Among managers we track Quote on Google Finance, opens in a new tab

No current holdings among managers we track for this security. See ownership history or the ownership grid, activity, or search.

Insider trades

Open-market buys and sales by BCPC's executives, directors and 10% owners in the last 12 months, from their Form 4s

All BCPC insider trades
  • None no insider bought on the open market
  • $2.3M sold by 3 insiders outside a trading plan
  • None no planned (10b5-1) sales
  1. David B Fischer Director
    Sale
    $1.2M 8,000 shares at $153.97 50% of stake
    Traded Dec 3, 2025 Filed Dec 5, 2025
    ↗
  2. Job Leonard Van Gunsteren SVP and GM, Specialty Products
    Sale
    $920K 6,000 shares at $153.29 39% of stake
    Traded Dec 4, 2025 Filed Dec 5, 2025
    ↗
  3. Martin Luther Reid SVP Chief Supply Chain Officer
    Sale
    $185K 1,200 shares at $154.44 14% of stake
    Traded Nov 11, 2025 Filed Nov 13, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 25 share withholdings for taxes, 23 stock grants, and 3 option exercises.

Congress

2 members of Congress traded BCPC in the last three years: 2 buys and 1 sale. 2 members listed it in 2025 annual reports.

All Congress trades
  1. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Sep 17 filed Oct 12
  2. Gilbert Ray Cisneros, Jr. D-CA-31 Buy $1K–$15K Jul 10 filed Sep 4
  3. Josh Gottheimer D-NJ-5Joint Partial sale $1K–$15K Apr 9, 2025 filed May 14, 2025

SEC filings

Recent issuer filings from EDGAR, 16 shown.

Filed Form Detail Links
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
8-K 1.01,2.03,9.01 Filing Doc
8-K 5.07 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
8-K 5.02,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 8 days ago. All on EDGAR

Financials

US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.

Income statement

Metric FY2023 FY2024 FY2025
Revenue $0.922B $0.954B $1.04B
Gross profit $302.06M $336.21M $370.63M
Gross margin * 32.7% 35.3% 35.7%
Net income $108.54M $128.48M $154.84M
Net margin * 11.8% 13.5% 14.9%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $314.24M $313.77M $365.61M
Total non-current assets * $1.28B $1.26B $1.32B
Total assets $1.6B $1.58B $1.69B
Total current liabilities $148.49M $157.68M $176.38M
Total non-current liabilities * $394.74M $267.77M $252.46M
Total equity $1.05B $1.15B $1.26B

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations $183.76M $182M $216.56M
Cash from investing -$34.81M -$59.74M -$43.89M
Cash from financing -$153.32M -$133.82M -$152.81M
Net change in cash -$2.11M -$14.93M $25.06M

Source: SEC companyfacts (US-GAAP 10-K). A * marks a computed figure, not a single XBRL tag. Fiscal years are as the issuer labels them. Follow The Filings does not adjust or audit these figures.

Ownership over time

13Fs that reported it each quarter. Click a bar for that quarter’s holders.